A surface plasmon resonance based approach for measuring response to pneumococcal vaccine

Abstract Incidence of pneumococcal disease has increased worldwide in recent years. Response to pneumococcal vaccine is usually measured using the multiserotype enzyme-linked immunosorbent assay (ELISA) pneumococcal test. However, this approach presents several limitations. Therefore, the introducti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Garrido-Jareño, Leonor Puchades-Carrasco, Leticia Orti-Pérez, José Miguel Sahuquillo-Arce, María del Carmen Meyer-García, Joan Mollar-Maseres, Carmina Lloret-Sos, Ana Gil-Brusola, José Luis López-Hontangas, José Manuel Beltrán-Garrido, Javier Pemán-García, Antonio Pineda-Lucena
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0cc2b5b8e2804eda85ce01928ae32afd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0cc2b5b8e2804eda85ce01928ae32afd
record_format dspace
spelling oai:doaj.org-article:0cc2b5b8e2804eda85ce01928ae32afd2021-12-02T13:24:14ZA surface plasmon resonance based approach for measuring response to pneumococcal vaccine10.1038/s41598-021-85958-02045-2322https://doaj.org/article/0cc2b5b8e2804eda85ce01928ae32afd2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85958-0https://doaj.org/toc/2045-2322Abstract Incidence of pneumococcal disease has increased worldwide in recent years. Response to pneumococcal vaccine is usually measured using the multiserotype enzyme-linked immunosorbent assay (ELISA) pneumococcal test. However, this approach presents several limitations. Therefore, the introduction of new and more robust analytical approaches able to provide information on the efficacy of the pneumococcal vaccine would be very beneficial for the clinical management of patients. Surface plasmon resonance (SPR) has been shown to offer a valuable understanding of vaccines’ properties over the last years. The aim of this study is to evaluate the reliability of SPR for the anti-pneumococcal capsular polysaccharides (anti-PnPs) IgGs quantification in vaccinated. Fast protein liquid chromatography (FPLC) was used for the isolation of total IgGs from serum samples of vaccinated patients. Binding-SPR assays were performed to study the interaction between anti-PnPs IgGs and PCV13. A robust correlation was found between serum levels of anti-PnPs IgGs, measured by ELISA, and the SPR signal. Moreover, it was possible to correctly classify patients into “non-responder”, “responder” and “high-responder” groups according to their specific SPR PCV13 response profiles. SPR technology provides a valuable tool for reliably characterize the interaction between anti-PnPs IgGs and PCV13 in a very short experimental time.Marta Garrido-JareñoLeonor Puchades-CarrascoLeticia Orti-PérezJosé Miguel Sahuquillo-ArceMaría del Carmen Meyer-GarcíaJoan Mollar-MaseresCarmina Lloret-SosAna Gil-BrusolaJosé Luis López-HontangasJosé Manuel Beltrán-GarridoJavier Pemán-GarcíaAntonio Pineda-LucenaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marta Garrido-Jareño
Leonor Puchades-Carrasco
Leticia Orti-Pérez
José Miguel Sahuquillo-Arce
María del Carmen Meyer-García
Joan Mollar-Maseres
Carmina Lloret-Sos
Ana Gil-Brusola
José Luis López-Hontangas
José Manuel Beltrán-Garrido
Javier Pemán-García
Antonio Pineda-Lucena
A surface plasmon resonance based approach for measuring response to pneumococcal vaccine
description Abstract Incidence of pneumococcal disease has increased worldwide in recent years. Response to pneumococcal vaccine is usually measured using the multiserotype enzyme-linked immunosorbent assay (ELISA) pneumococcal test. However, this approach presents several limitations. Therefore, the introduction of new and more robust analytical approaches able to provide information on the efficacy of the pneumococcal vaccine would be very beneficial for the clinical management of patients. Surface plasmon resonance (SPR) has been shown to offer a valuable understanding of vaccines’ properties over the last years. The aim of this study is to evaluate the reliability of SPR for the anti-pneumococcal capsular polysaccharides (anti-PnPs) IgGs quantification in vaccinated. Fast protein liquid chromatography (FPLC) was used for the isolation of total IgGs from serum samples of vaccinated patients. Binding-SPR assays were performed to study the interaction between anti-PnPs IgGs and PCV13. A robust correlation was found between serum levels of anti-PnPs IgGs, measured by ELISA, and the SPR signal. Moreover, it was possible to correctly classify patients into “non-responder”, “responder” and “high-responder” groups according to their specific SPR PCV13 response profiles. SPR technology provides a valuable tool for reliably characterize the interaction between anti-PnPs IgGs and PCV13 in a very short experimental time.
format article
author Marta Garrido-Jareño
Leonor Puchades-Carrasco
Leticia Orti-Pérez
José Miguel Sahuquillo-Arce
María del Carmen Meyer-García
Joan Mollar-Maseres
Carmina Lloret-Sos
Ana Gil-Brusola
José Luis López-Hontangas
José Manuel Beltrán-Garrido
Javier Pemán-García
Antonio Pineda-Lucena
author_facet Marta Garrido-Jareño
Leonor Puchades-Carrasco
Leticia Orti-Pérez
José Miguel Sahuquillo-Arce
María del Carmen Meyer-García
Joan Mollar-Maseres
Carmina Lloret-Sos
Ana Gil-Brusola
José Luis López-Hontangas
José Manuel Beltrán-Garrido
Javier Pemán-García
Antonio Pineda-Lucena
author_sort Marta Garrido-Jareño
title A surface plasmon resonance based approach for measuring response to pneumococcal vaccine
title_short A surface plasmon resonance based approach for measuring response to pneumococcal vaccine
title_full A surface plasmon resonance based approach for measuring response to pneumococcal vaccine
title_fullStr A surface plasmon resonance based approach for measuring response to pneumococcal vaccine
title_full_unstemmed A surface plasmon resonance based approach for measuring response to pneumococcal vaccine
title_sort surface plasmon resonance based approach for measuring response to pneumococcal vaccine
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0cc2b5b8e2804eda85ce01928ae32afd
work_keys_str_mv AT martagarridojareno asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT leonorpuchadescarrasco asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT leticiaortiperez asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT josemiguelsahuquilloarce asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT mariadelcarmenmeyergarcia asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT joanmollarmaseres asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT carminalloretsos asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT anagilbrusola asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT joseluislopezhontangas asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT josemanuelbeltrangarrido asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT javierpemangarcia asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT antoniopinedalucena asurfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT martagarridojareno surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT leonorpuchadescarrasco surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT leticiaortiperez surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT josemiguelsahuquilloarce surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT mariadelcarmenmeyergarcia surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT joanmollarmaseres surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT carminalloretsos surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT anagilbrusola surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT joseluislopezhontangas surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT josemanuelbeltrangarrido surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT javierpemangarcia surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
AT antoniopinedalucena surfaceplasmonresonancebasedapproachformeasuringresponsetopneumococcalvaccine
_version_ 1718393074236784640